The statement came amid reports that Cipla was seeking fast-track approvals to bring Moderna’s single-dose Covid-19 booster vaccine into India expeditiously. Multinational pharmaceutical company Cipla Limited on Tuesday confirmed it was working to import Covid-19 vaccines to India and said it is in the process of seeking clarity and guidance from the government for the possible roadmap for it. In a statement, the company said at this stage, no definitive terms have been finalized and hence it cannot comment further.